| evidence basis for antimalarial policy change in sierra leone: five in vivo efficacy studies of chloroquine, sulphadoxine-pyrimethamine and amodiaquine. | to provide nationally relevant information on the antimalarial efficacy of chloroquine (cq), sulphadoxine-pyrimethamine (sp) and amodiaquine (aq) in sierra leone, with a view to updating antimalarial policy in the country. | 2005 | 15679557 |
| baseline health conditions in selected communities of northern sierra leone as revealed by the health impact assessment of a biofuel project. | as biofuel projects may be associated with positive and negative effects on people's health and wellbeing, a health impact assessment was performed for the addax bioenergy sierra leone (absl) project. we present data from the baseline health survey, which will provide a point of departure for future monitoring and evaluation activities. | 2014 | 24984863 |
| changing patterns of health in communities impacted by a bioenergy project in northern sierra leone. | large private sector investments in low- and middle-income countries are often critically evaluated with regards to their environmental, social, human rights, and health impacts. a health impact assessment, including a baseline health survey, was commissioned by the addax bioenergy sierra leone project in 2010. as part of the monitoring, a follow-up survey was conducted three years later. a set of health indicators was assessed at six impacted and two control sites. most of these indices improve ... | 2014 | 25514152 |